Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Clinical evidence and trial services / Medical-device and diagnostic post-market coverage evidence
Medical-device and diagnostic post-market coverage evidence
Medical-device and diagnostic vendors needing post-market observational studies, real-world evidence, patient and site management, data management and evidence updates to support payer coverage, indication expansion or lifecycle management after initial market entry.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Medical-device and diagnostic vendors
- Buying centre
- HEOR/market access, post-market and clinical affairs, regulatory affairs, medical affairs
- Payer coverage or reimbursement decision
- Post-market clinical study requirement
- Label or indication expansion
- Payer request for updated real-world evidence
- Delayed availability of post-market real-world evidence
- Inconsistent evidence across studies and data sources
- Long and unpredictable payer evidence cycles
- Increasing post-approval and lifecycle evidence burden
How this was sized
Not sized yet
No supplied source isolates post-market payer-evidence services for medical-device and diagnostic vendors. Published healthcare regulatory-outsourcing totals in [3], [5], [6], [7], [8], [9] and [10] include broader consulting, submissions, writing, publishing and product-registration services and are therefore not used as a proxy. Source [5] identifies post-approval and lifecycle-maintenance burden as a demand driver, while [10] reports strong regulatory-outsourcing growth, but neither supports a niche revenue figure.
Alongside it in Clinical evidence and trial services
// Sell into Medical-device and diagnostic post-market coverage evidence